🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Diaphragmatic Release for Low Back Pain

RecruitingNAAges 18 Years - 65 YearsAllKarabuk University
NCT07298109 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Low back pain is one of the most common musculoskeletal disorders, significantly affecting the quality of life of individuals. In non-specific low back pain, a lack of stabilization in the core region negatively impacts the performance of activities. The diaphragm forms the framework of the core region, and its dysfunction can contribute to both respiratory problems and low back pain. This study will investigate the effects of diaphragm relaxation, added to spinal stabilization exercises, on pain, disability, quality of life, central sensitization, and trunk muscle endurance.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Being between 18-65 years of age * Having been diagnosed with chronic non-specific lower back pain (pain between the gluteal folds and the 12th ribs lasting at least 12 weeks and without a known pathoanatomical cause) * Being willing to participate in the study Exclusion Criteria: * Psychological disorders, mental disorders, cancer, and severe depression * History of primary or metastatic spinal malignancy or spinal fracture * Neurological disease (Hemiplegia, Multiple Sclerosis, Parkinson's, etc.) * Having been diagnosed with advanced osteoporosis * Having undergone previous surgery or had an acute infection in the lumbar region
💊

What it tests

  • Manual diaphragm release
  • Control
📍

Where

1 site
Karabuk University, Physiotherapy and Rehabilitation Application and Research Center
Karabük, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy